George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Convertible Loan Note

18 Nov 2009 07:23

RNS Number : 6801C
Plethora Solutions Holdings PLC
18 November 2009
 



18 November 2009

 

PLETHORA SOLUTIONS HOLDINGS PLC

Placing of New Shares and Issue of Convertible Loan Note

Roll-out of The Urology Company Limited

Plethora Solutions Holdings PLC ("Plethora", AIM: PLE), a UK based specialty pharmaceutical company, announces that it has concluded an agreement to raise £1.57 million via a Placing of New Ordinary Shares and New Convertible Loan Notes. 

The Placing 

The Placing comprises New Ordinary Shares and New Convertible Loan Notes which have been placed, subject to the successful passing of certain resolutions at a General Meeting of the shareholders, with new and existing investors. £1.12m has been raised through the issue of 11,150,000 New Ordinary Shares of 1p each at a placing price of 10p per share. The New Ordinary Shares will rank pari pasu with the existing ordinary shares of the Company. Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM and it is anticipated that trading will commence on Tuesday 8 December 2009. A further £450,000 has been raised by issuance of New Convertible Loan Notes due December 2012 bearing a 13% coupon and convertible at 12.5p. These loan notes may convert into 3,600,000 shares In addition, existing holders of two convertible loan notes, in aggregate being £1.75 million, have agreed that the terms of the existing loan notes will be brought onto the same basis as the New Convertible Loan Notes. The amendments will include extending the maturity of both existing convertible loan notes from September 2010 and January 2011 to December 2012. This improves the Company's liquidity profile by moving maturity to a later period.

The Directors have, as part of the Placing, committed to subscribe for 1.95 million new shares raising £195,000, being 12.5% of the total amount raised through the conduct of the fundraising. Details of the Directors' holdings will be published separately.

The Placing is subject to approval by shareholders at a General Meeting to be held at 9:00am on Monday 7th December. Details and Notice of the meeting are included in a circular which is being sent to shareholders today and is available on the Company's web site. 

Use of Proceeds

The net proceeds of the fundraising, estimated to be £1.5 million, will provide additional working capital to take the Group to revenue generation in the near term from product sales from its new subsidiary, The Urology Company Limited, and from high value, medium term licensing income from its clinical assets.

The Urology Company Limited

New funds will provide working capital for the roll out of a new subsidiary, The Urology Company Limited, which will market and distribute a portfolio of therapeutic products to UK urology clinics.

First sales are expected to be generated through this new venture in the first half of 2010.

Funding PSD502 and PSD503 through to revenue generation

To date two late stage clinical assets, PSD502 for the treatment of premature ejaculation and PSD503 for the treatment of stress urinary incontinence, have been licensed or acquired by pharmaceutical companies for which the Plethora Group expects to receive milestone and royalty income in the near term. 

The new working capital will enable the Company to provide support to its partners through to the point where revenues flow from the license agreements.

Dr Steven Powell, CEO of Plethora, commented: "We are delighted to now have the financial resources to complete the transition of Plethora from a cash consuming, development lead company into a sustainable urology business with revenue flowing from both near term product sales and high value, medium term licensing income. We are grateful to both existing and new investors whose financial support should enable us to steer the Company to profitability".

-Ends-

  Enquiries:

Plethora Solutions

Steven Powell/Ronald Openshaw

Tel : +44(0) 20 3077 5400

FinnCap

Geoff Nash/Marc Young

Tel : +44(0) 20 7600 1658

Hansard Group

John Bick

Tel: +44(0) 20 7245 1100

Tel: +44(0)7872 061007

About Plethora:

Plethora is a specialty pharmaceutical company focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder (PSD506), stress urinary incontinence (PSD503), interstitial cystitis (PSD597), gynaecological pain (PSD508), erectile dysfunction (PSD510) and premature ejaculation (PSD502). Plethora's subsidiary, The Urology Company Limited, was established in 2009 to market and distribute a range of therapeutic products for the management and treatment of urology, andrology and obstetric conditions. The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM:PLE) 

Further information is available at www.plethorasolutions.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUWUBRKURAARA
Date   Source Headline
9th Mar 20168:15 amRNSScheme becomes Effective
8th Mar 20164:44 pmRNSCourt Sanction of Scheme - Replacement
8th Mar 20163:12 pmRNSScheme becomes Effective
8th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
8th Mar 20167:30 amRNSSuspension - Plethora Solutions Holdings Plc
7th Mar 20161:36 pmRNSSuspension of trading of Shares
7th Mar 20169:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
4th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
3rd Mar 20165:25 pmRNSR&D Tax Credit Receipt and Director Dealing
3rd Mar 201611:47 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
2nd Mar 201612:00 pmRNSResult of Shareholder and Court Meetings
2nd Mar 201611:20 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
1st Mar 201610:23 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
29th Feb 201611:14 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
26th Feb 20167:34 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
25th Feb 20169:33 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
24th Feb 20169:00 amRNSLetter of Intent Signed
24th Feb 20168:50 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
23rd Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
22nd Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
19th Feb 20167:50 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
18th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
17th Feb 201611:30 amRNSDisposal of Shares in Endeavour Mining Corporation
17th Feb 20168:29 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
16th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
15th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
12th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
11th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
11th Feb 20168:28 amRNSExpected timetable for suspension and de-listing
10th Feb 201611:35 amBUSForm 8.3 - Plethora Solutions Holdings Plc
10th Feb 20169:30 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
9th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20168:11 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
5th Feb 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions Hldgs PLC
4th Feb 20169:00 amRNSPosting Scheme Document & Plethora Trading Update
3rd Feb 20169:29 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
2nd Feb 20162:52 pmRNSForm 8.3 - Plethora Solutions Holdings Plc
2nd Feb 20168:11 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
1st Feb 20168:34 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
29th Jan 20168:34 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
28th Jan 20169:06 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
27th Jan 20169:01 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
26th Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
26th Jan 20169:00 amRNSTrading Update
25th Jan 20169:24 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
25th Jan 20169:00 amRNSOffer Update
22nd Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions Hldgs PLC
21st Jan 20169:02 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
20th Jan 20169:00 amRNSForm 8 (OPD) (Plethora Solutions) - Replacement
20th Jan 20168:30 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.